sclerosing cholangitis: A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions
Apply sex-specific rule None
K11_CHOLANGI_STRICT
Extra metadata
List of similar endpoints to
Cholangitis (primary sclerosing, PSC), with reimbursement 202
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 309 | 175 | 134 |
| Unadjusted prevalence (%) | 0.12 | 0.12 | 0.12 |
| Mean age at first event (years) | 42.99 | 45.52 | 39.70 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | - | - | - | - |
| 15 years | - | - | - | - |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: K11_CHOLANGI_STRICT – Cholangitis (primary sclerosing, PSC), with reimbursement 202
GWS hits: 1
before Cholangitis (primary sclerosing, PSC), with reimbursement 202
after Cholangitis (primary sclerosing, PSC), with reimbursement 202
Loading survival analyses plot
Loading survival analyses table